NCT05066607 2024-03-06
IsAMYP
Intergroupe Francophone du Myelome
Phase 2 Unknown
Clinical Trials
5 trialsNCT03792620 2019-01-03
MAXDARA
Grupo de Estudos Multicentricos em Onco-Hematologia
Phase 3 Unknown
NCT02270307 2014-10-21
MSC-CY
National Research Center for Hematology, Russia
Phase 2/3 Unknown
NCT01532856 2012-02-15
Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years
Grupo de Estudos Multicentricos em Onco-Hematologia
Phase 3 Unknown
NCT00910897 2009-06-01
Study in Myeloma Patients Newly Diagnosed Treated as an Induction With Velcade-Dex or Velcade (Bortezomib) Thalidomide Dexamethasone (VTD)
Intergroupe Francophone du Myelome
Phase 3 Unknown